Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Study shows AI tool's high accuracy in answering genetic counseling questions

An artificial intelligence tool correctly answered 83 percent of common genetic counseling questions, including those about genetic testing and genetic syndromes, a new study found.

18 Mar 2024

Researchers develop an algorithm to identify high-risk precancerous lesions on the fallopian tubes

Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine have developed an algorithm to identify high-risk precancerous lesions on the fallopian tubes.

14 Mar 2024

Women with germ cell tumors have worse prognosis than men with similar cancers

Women with a type of ovarian cancer known as germ cell tumors have a worse prognosis than men with similar tumors, i.e. testicular cancer.

12 Mar 2024

Zika virus live-attenuated vaccine strains show promise in brain cancer treatment

Scientists from Duke-NUS Medical School (Duke-NUS) have developed a new approach using the Zika virus to destroy brain cancer cells and inhibit tumor growth, while sparing healthy cells.

8 Mar 2024

Researchers develop new algorithm to identify high-risk precancerous lesions on the fallopian tubes

6 Mar 2024

New approach needed to better prepare and support women during menopause transition, experts say

A new approach to menopause that better prepares and supports women during midlife is needed – going beyond medical treatments, to empower women using high-quality information on symptoms and treatments, empathic clinical care and workplace adjustments as required, says a new four paper Series published in The Lancet.

6 Mar 2024

Harnessing repetitive DNA for early cancer detection

People with cancer have different amounts of a type of repetitive DNA -; called Alu elements -; than people without cancer.

4 Mar 2024

Study highlights the role of slower usual walking pace in ovarian cancer risk

Announcing a new article publication for BIO Integration journal. This study was aimed at exploring the causal relationships of four sarcopenia-related traits (appendicular lean mass, usual walking pace, right hand grip strength, and levels of moderate to vigorous physical activity) with body mass index (BMI) and ovarian cancer risk, by using univariable and multivariable Mendelian randomization (MR) methods.

4 Mar 2024

Study reveals high prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from the Salento peninsula

A new research paper was published in Oncotarget's Volume 15 on February 22, 2024, entitled, "Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health."

28 Feb 2024

Breakthrough research could transform the landscape of ovarian cancer treatment

In a major scientific breakthrough, newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.

27 Feb 2024

UK lags in cancer treatment compared to other countries

People in the UK were treated with chemotherapy and radiotherapy less often than in comparable countries and faced long waits for treatments, according to two new studies published in The Lancet Oncology.

26 Feb 2024

Scientists discover the Achilles heel of chemotherapy-resistant ovarian cancer

Women diagnosed with ovarian cancer may initially respond well to chemotherapy, but the majority of them will develop resistance to treatment and die from the disease.

21 Feb 2024

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin Lee, PhD, in the Department of Physiology, and David Schwartz, MD, chair of the Department of Radiation Oncology, are part of a scientific leadership group awarded $20 million from the University of Tennessee-Oak Ridge Innovation Institute in partnership with Oak Ridge National Laboratory and the University of Tennessee, Knoxville, to develop new radiopharmaceutical therapies to treat cancer.

21 Feb 2024

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.

21 Feb 2024

Gynecologic cancer patients and advocates unite at FWC Forum in San Diego

The Foundation for Women's Cancer (FWC) is pleased to host a Patient and Advocate Education Forum on Friday, March 15, 2024, 10 a.m. – 4:30 p.m. PT, in San Diego, CA, at the San Diego Convention Center the day before the start of the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women's Cancer.

15 Feb 2024

Smoking, drinking, and dietary habits linked to head and neck cancer risk, study finds

Study in JAMA Otolaryngology-Head & Neck Surgery examines the link between smoking, drinking, and dietary habits and the risk of developing head and neck cancer (HNC), highlighting the significant impact of lifestyle choices on cancer risk.

12 Feb 2024

New method traces primed resistance in cancer via sister cells

In many cancers, such as ovarian cancer, each round of chemotherapy kills the majority of cancer cells, while a small population of them survives through treatment.

12 Feb 2024

New research shows promise for urine-based test to detect ovarian cancer

New research by Joseph Reiner and colleagues at Virginia Commonwealth University shows promise for a urine-based test for ovarian cancer. Reiner will present their research at the 68th Biophysical Society Annual Meeting, to be held February 10 - 14, 2024 in Philadelphia, Pennsylvania.

12 Feb 2024

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Once they enter the body, drugs, apart from carrying out their therapeutic function, are biochemically transformed by the action of the metabolic machinery, a process that facilitates their expulsion.

9 Feb 2024

FDA’s plan to ban hair relaxer chemical called too little, too late

In April, a dozen years after a federal agency classified formaldehyde a human carcinogen, the Food and Drug Administration is tentatively scheduled to unveil a proposal to consider banning the chemical in hair-straightening products.

8 Feb 2024

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Study shows AI tool's high accuracy in answering genetic counseling questions

Researchers develop an algorithm to identify high-risk precancerous lesions on the fallopian tubes

Women with germ cell tumors have worse prognosis than men with similar cancers

Zika virus live-attenuated vaccine strains show promise in brain cancer treatment

Researchers develop new algorithm to identify high-risk precancerous lesions on the fallopian tubes

New approach needed to better prepare and support women during menopause transition, experts say

Harnessing repetitive DNA for early cancer detection

Study highlights the role of slower usual walking pace in ovarian cancer risk

Study reveals high prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from the Salento peninsula

Breakthrough research could transform the landscape of ovarian cancer treatment

UK lags in cancer treatment compared to other countries

Scientists discover the Achilles heel of chemotherapy-resistant ovarian cancer

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

Gynecologic cancer patients and advocates unite at FWC Forum in San Diego

Smoking, drinking, and dietary habits linked to head and neck cancer risk, study finds

New method traces primed resistance in cancer via sister cells

New research shows promise for urine-based test to detect ovarian cancer

Rucaparib and its major metabolite exhibit differential biological activity and synergy

FDA’s plan to ban hair relaxer chemical called too little, too late

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Newsletters you may be interested in